Legend Biotech Corporation
LEGN
$19.91
-$0.58-2.83%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 27.01% | -0.45% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 27.01% | -0.42% | |||
| Cost of Revenue | -21.89% | 42.48% | |||
| Gross Profit | 93.58% | -29.37% | |||
| SG&A Expenses | 6.99% | -10.96% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | 220.00% | |||
| Total Operating Expenses | -7.07% | 8.54% | |||
| Operating Income | 215.86% | -141.72% | |||
| Income Before Tax | 204.52% | -170.93% | |||
| Income Tax Expenses | 1,758.33% | -89.30% | |||
| Earnings from Continuing Operations | 161.14% | -76.21% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 161.14% | -76.21% | |||
| EBIT | 215.86% | -141.72% | |||
| EBITDA | 230.17% | -164.58% | |||
| EPS Basic | 160.50% | -75.90% | |||
| Normalized Basic EPS | 203.46% | -157.61% | |||
| EPS Diluted | 159.17% | -66.02% | |||
| Normalized Diluted EPS | 199.83% | -157.61% | |||
| Average Basic Shares Outstanding | 1.03% | 0.20% | |||
| Average Diluted Shares Outstanding | 4.70% | 0.20% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||